Longitudinal study of schizophrenic patients: factors influencing social autonomy FRESH-PEF73225-en Isabelle GASQUET Longitudinal study of schizophrenic patients: factors influencing social autonomy ESPASS FRESH-PEF73225-en 73225 FRESH-PEF73225 Jean-Michel AZORIN Isabelle GASQUET Denis LEGUAY INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) Epidemiology France Portal (PEF) BRISTOL MYERS SQUIBB PHARMA FRANCE S.A OTSUKA PHARMACEUTICAL FRANCE SAS null Isabelle;GASQUET Denis;LEGUAY schizophrenia care social life satisfaction Psychiatry Schizophrenia Behavioral determinants Healthcare system determinants: Use of care Socio-demographic and economic determinants Healthcare system determinants The objective of the ESPASS pharmacoepidemiological study is to evaluate the impact at 6 months of the change or the introduction of the main antipsychotic treatment on the social autonomy of patients with schizophrenia according to the possible pathway to autonomy put in place. null France Individuals Patients population Male Female Young Adult (19 to 24 years) Adult (25 to 44 years) Middle Aged (45 to 64 years) Aged (65 to 79 years) Aged, 80 and over (80 years and more) Patients were required to meet the DSM-IV TR diagnostic criteria for schizophrenia, requiring an initiation of or change in antipsychotic therapy for any reason, they should not meet the criteria of an acute psychotic episode and should not require a normothymic drug Clinical data Participant-reported health data Health event/morbidity Health care consumption and services Quality of life/health perception Other Through organizations (health services or institutions schools businesses etc.) [1000-10000[ individuals Converting or copying information into a structured record Interview with the participant (including clinical) Observational Study Observational Study 6165 Unknown Restricted access Contact the principal investigator Access on specific project only